Prognostic significance of circulating tumour biomarkers in patients treated with curative-intent radiotherapy for NSCLC

在澳大利亚，超过50%的癌症患者接受放射治疗，但许多人后来死于远处转移。这项关于循环生物标志物（血液中的肿瘤细胞和DNA）的研究建立在彼得·麦克研究所的研究证据的基础上，该研究表明，一些肺癌在放疗治疗期间可能会扩散，否则这些肺癌是可以治愈的。这项研究将有助于确定继发性癌症的高风险癌症患者，并允许我们修改治疗方法以预防它们。

More than 50% of cancer patients in Australia receive radiotherapy but many later die from distant metastases. This study of circulating biomarkers (tumour cells and DNA in the bloodstream) builds on evidence from research at Peter Mac showing that some lung cancers might spread during treatment with radiotherapy that would otherwise be curative. This study will help identify cancer patients at high risk of secondary cancers and could allow us to modify treatments to prevent them.